Shenzhen New Industries Biomedical (300832) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.069x

Based on the latest financial reports, Shenzhen New Industries Biomedical (300832) has a cash flow conversion efficiency ratio of 0.069x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥606.21 Million ≈ $88.71 Million USD) by net assets (CN¥8.74 Billion ≈ $1.28 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Shenzhen New Industries Biomedical (300832) market capitalisation for the company's overall valuation and market capitalisation.

Shenzhen New Industries Biomedical - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Shenzhen New Industries Biomedical's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Shenzhen New Industries Biomedical Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shenzhen New Industries Biomedical ranked by their cash flow conversion efficiency. Explore earnings quality score of Shenzhen New Industries Biomedical to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
ChinaLin Securities Co Ltd SHE:002945	0.997x
AutoNation Inc NYSE:AN	0.010x
Sundaram Finance Limited NSE:SUNDARMFIN	-0.206x
Hoshine Silicon Ind Co Ltd SHG:603260	0.007x
Birkenstock Holding plc NYSE:BIRK	0.008x
Ultrapar Participações S.A F:UGR	0.134x
Strathcona Resources Ltd. TO:SCR	0.044x
Corcept Therapeutics Incorporated NASDAQ:CORT	-0.026x

Annual Cash Flow Conversion Efficiency for Shenzhen New Industries Biomedical (2012–2024)

The table below shows the annual cash flow conversion efficiency of Shenzhen New Industries Biomedical from 2012 to 2024. View latest Shenzhen New Industries Biomedical stock price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥8.58 Billion ≈ $1.26 Billion	CN¥1.36 Billion ≈ $198.49 Million	0.158x	-15.87%
2023-12-31	CN¥7.54 Billion ≈ $1.10 Billion	CN¥1.42 Billion ≈ $207.54 Million	0.188x	+25.01%
2022-12-31	CN¥6.40 Billion ≈ $936.45 Million	CN¥962.39 Million ≈ $140.83 Million	0.150x	+9.15%
2021-12-31	CN¥5.61 Billion ≈ $821.21 Million	CN¥773.22 Million ≈ $113.15 Million	0.138x	-32.23%
2020-12-31	CN¥4.80 Billion ≈ $703.01 Million	CN¥976.65 Million ≈ $142.92 Million	0.203x	-23.28%
2019-12-31	CN¥3.14 Billion ≈ $459.30 Million	CN¥831.73 Million ≈ $121.71 Million	0.265x	-10.68%
2018-12-31	CN¥2.37 Billion ≈ $346.26 Million	CN¥701.97 Million ≈ $102.72 Million	0.297x	+0.19%
2017-12-31	CN¥1.77 Billion ≈ $259.33 Million	CN¥524.73 Million ≈ $76.78 Million	0.296x	-13.68%
2016-12-31	CN¥1.42 Billion ≈ $207.68 Million	CN¥486.81 Million ≈ $71.24 Million	0.343x	+14.71%
2015-12-31	CN¥1.02 Billion ≈ $149.72 Million	CN¥305.93 Million ≈ $44.77 Million	0.299x	-27.98%
2014-12-31	CN¥610.52 Million ≈ $89.34 Million	CN¥253.47 Million ≈ $37.09 Million	0.415x	+13.70%
2013-12-31	CN¥378.84 Million ≈ $55.44 Million	CN¥138.33 Million ≈ $20.24 Million	0.365x	+62.39%
2012-12-31	CN¥248.18 Million ≈ $36.32 Million	CN¥55.80 Million ≈ $8.17 Million	0.225x	--

About Shenzhen New Industries Biomedical

SHE:300832 China Medical Devices

Market Cap

$5.63 Billion

CN¥38.45 Billion CNY

Market Cap Rank

#3300 Global

#437 in China

Share Price

CN¥48.94

Change (1 day)

-0.29%

52-Week Range

CN¥39.45 - CN¥68.40

All Time High

CN¥98.01